These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 37483632)

  • 1. Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy.
    Kamiya M; Kimura N; Umezawa N; Hasegawa H; Yasuda S
    Front Immunol; 2023; 14():1191815. PubMed ID: 37483632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis.
    Kamiya M; Mizoguchi F; Yasuda S
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2118-2131. PubMed ID: 35775116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?
    Lightfoot AP; McArdle A; Jackson MJ; Cooper RG
    Ann Rheum Dis; 2015 Jul; 74(7):1340-6. PubMed ID: 26063809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies.
    Kamiya M; Mizoguchi F; Kawahata K; Wang D; Nishibori M; Day J; Louis C; Wicks IP; Kohsaka H; Yasuda S
    Nat Commun; 2022 Jan; 13(1):166. PubMed ID: 35013338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study of contractile force production in muscle fibers from patients with inflammatory myopathies.
    Henning F; Kohn TA
    Muscle Nerve; 2020 Aug; 62(2):284-288. PubMed ID: 32367547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies.
    Grundtman C; Bruton J; Yamada T; Ostberg T; Pisetsky DS; Harris HE; Andersson U; Lundberg IE; Westerblad H
    FASEB J; 2010 Feb; 24(2):570-8. PubMed ID: 19837864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Necroptosis to Myofiber Death in Idiopathic Inflammatory Myopathies.
    Peng QL; Zhang YM; Liu YC; Liang L; Li WL; Tian XL; Zhang L; Yang HX; Lu X; Wang GC
    Arthritis Rheumatol; 2022 Jun; 74(6):1048-1058. PubMed ID: 35077006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?
    Loell I; Lundberg IE
    J Intern Med; 2011 Mar; 269(3):243-57. PubMed ID: 21205023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neutrophil extracellular traps and proinflammatory damage-associated molecular patterns in idiopathic inflammatory myopathies.
    Ma W; Zhu J; Bai L; Zhao P; Li F; Zhang S
    Clin Exp Immunol; 2023 Jul; 213(2):202-208. PubMed ID: 37289984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.
    Coley W; Rayavarapu S; Nagaraju K
    Arthritis Res Ther; 2012 Apr; 14(2):209. PubMed ID: 22546362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic inflammatory myopathies from the viewpoint of a neurologist].
    Shimizu J
    Brain Nerve; 2013 Nov; 65(11):1269-74. PubMed ID: 24200604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.
    Zhen C; Hou Y; Zhao B; Ma X; Dai T; Yan C
    Front Immunol; 2022; 13():1051609. PubMed ID: 36578492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
    Mandel DE; Malemud CJ; Askari AD
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
    Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
    J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.
    Khadilkar SV; Dhamne MC
    Ann Indian Acad Neurol; 2020; 23(4):458-467. PubMed ID: 33223661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement.
    Liu M; Hou Y; Dai T; Lv J; Li W; Zhao Y; Fang Q; Yan C
    J Clin Neurosci; 2019 Jul; 65():46-53. PubMed ID: 31060889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis an evolving spectrum of disease.
    Barsotti S; Lundberg IE
    Immunol Med; 2018 Jun; 41(2):46-54. PubMed ID: 30938263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.
    Grundtman C; Malmström V; Lundberg IE
    Arthritis Res Ther; 2007; 9(2):208. PubMed ID: 17389031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.